The central role of this pathway was demonstrated by the finding that mice lacking both Tak1 and Tgfbr2 (or Smad4) showed reduced liver injury, fibrosis, and HCC (Yang et al., 2013). The gene discussed is SMAD4; the disease is hepatocellular carcinoma.